376. Venture: Dennis McWilliams of Santé Ventures

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures, about what makes a medtech company investable at the early stage.From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplined capital strategy shapes outcomes.The episode highlights companies like Farapulse, Laminar, Endogenex, and Sonire Therapeutics, and the role of strategics like Medtronic, Boston Scientific, and Johnson and Johnson in driving acquisitions and growth.A focused look at how medtech capital really moves.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Harsh Truth About Startup Failure and Capital Risk00:12 Corporate Venture vs Traditional VC01:05 Intro + Dennis McWilliams (Sante Ventures)02:26 Dennis Background: From Aerospace to MedTech06:05 Why MedTech is Harder Than SaaS08:04 Lessons from Fund IV and Market Cycles11:51 Investment Strategy: Early Stage Focus13:58 Why Valuation Discipline Matters 16:31 Why Sante Stays Early Stage18:01 Early vs Late Stage Investing Tradeoffs21:21 Notable Wins: Cardiovascular and M&A Success23:32 What Makes a Winning MedTech Company23:39 Sante Investment Filter Explained26:06 Evaluating New Markets and White Space28:05 How VCs Find Startups30:00 Advice for Founders Raising Capital33:12 Minimum Requirements to Pitch a VC35:41 Founder vs Experienced CEO Debate39:52 When Founders Get Replaced42:22 What VCs Look for in Founders43:48 Corporate Venture Capital Explained46:32 Risks and Dynamics of Corporate Investors48:00 Founder Mistakes with Equity48:56 Why Dilution is Misunderstood51:51 Biggest Startup Mistakes (Valuations)53:00 How Long VC Decisions Really Take56:13 New Investment Spotlight (Oncology)57:36 Rapid Fire: Learning Venture Capital01:00:01 How Venture Really Works Behind the Scenes01:02:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #venturecapital #startupfunding #healthcareinnovation #entrepreneurship